Analysis
Who makes Ozempic, Wegovy and Zepbound?
Identify Novo Nordisk and Eli Lilly's brands, and distinguish the manufacturer from a telehealth platform, prescribing practice, pharmacy or compounder.
Claims are checked against the sources cited in this article. Nothing here is individualized medical advice. How we research
On this page
Ozempic and Wegovy are Novo Nordisk brands; Zepbound is an Eli Lilly and Company brand. A telehealth platform or pharmacy offering access to one of them is not thereby its manufacturer. The official Ozempic label, Wegovy label and Lilly medicine directory establish the company associations. Sources were checked October 9, 2026.
Brand names and companies at a glance
| Brand | Ingredient named in the official product source | Company associated with the branded product |
|---|---|---|
| Ozempic | Semaglutide | Novo Nordisk |
| Wegovy | Semaglutide | Novo Nordisk |
| Zepbound | Tirzepatide | Eli Lilly and Company |
The Ozempic label identifies Novo Nordisk A/S as manufacturer. Wegovy’s U.S. labeling identifies Novo Nordisk Inc. as marketer and Novo Nordisk A/S as the trademark owner. Lilly’s current medicine directory lists Zepbound as its product. These are company and product identifiers, not a claim that the medicines are interchangeable or approved for identical uses.
Our semaglutide guide and tirzepatide guide provide directory context. Ingredient names help identify which product is being discussed, but they should not replace the full brand and presentation in a pharmacy quote.
Why more than one company name can appear in your purchase
A prescription transaction can involve a manufacturer, a clinician’s practice, a technology platform and a dispensing pharmacy. Each performs a different role, and the website where you begin may not own or operate every participant.
The medicine brand answers one question: which company’s branded product is being offered? The service agreement answers another: who provides and bills for the care or platform? The dispensing label identifies the pharmacy involved in the actual order. Treat those identities as separate pieces of information.
This matters when reading claims such as “our GLP-1 program” or “our medication options.” A provider can organize access to a branded medicine without manufacturing it. A pharmacy can dispense the medicine without owning the brand. Neither relationship can be inferred solely from a logo or referral link.
Manufacturer access programs are not always the dispensing company
NovoCare is Novo’s access and pricing resource, but its pharmacy page identifies CoAssist Pharmacy doing business as NovoCare Pharmacy and describes pharmacy partners. Novo’s pharmacy explanation distinguishes those operating roles.
Similarly, a LillyDirect link is a manufacturer-associated purchase channel rather than proof that every company involved in fulfillment is the same legal entity as Lilly. Use the actual pharmacy information and current program terms to identify who handles an order. LillyDirect’s Zepbound page provides the official channel reference.
For a reader, the practical question is not merely whose name is most prominent. Ask which organization handles prescription processing, payment, shipment and order support. Those responsibilities determine where an administrative question should go.
A telehealth platform is a separate participant
Ro, for example, describes its platform and affiliated medical providers separately in its terms. Its pricing page also separates membership and medication charges. Our Ro profile provides the corresponding service context; it does not identify Ro as the maker of Ozempic, Wegovy or Zepbound.
The same distinction should be applied to other services. Check the current agreement for the named clinical practice and dispensing pharmacy rather than assuming the consumer brand performs every function. A convenient single website can still coordinate several independent billing or professional relationships.
When comparing providers, ask who collects each required payment. A membership fee, pharmacy charge and diagnostic bill should not be merged into a vague “manufacturer price.” The manufacturer’s offer can explain one part of the expense without establishing the total care-service cost.
Compounded products are not those branded products
A compounded semaglutide offer is not automatically Ozempic or Wegovy, and a compounded tirzepatide offer is not automatically Zepbound. FDA states that compounded medicines are not FDA-approved and do not receive its premarket review. FDA’s compounding questions and answers explain the regulatory distinction.
If an offer is compounded, ask which pharmacy prepares and dispenses it. Do not identify Novo or Lilly as that compounder’s manufacturer simply because a familiar ingredient name appears in the advertisement. A comparison needs the actual product category and responsible pharmacy, not a borrowed brand label.
Our compounded semaglutide price comparison and compounded tirzepatide comparison keep those offers in separate categories. They describe pricing and commitments, not clinical equivalence or manufacturer endorsement.
Which organization should answer your question?
For a pharmacy order, use the dispensing pharmacy’s verified contact information. For a membership charge or account access, use the platform’s relevant support channel. For a prescription or treatment question, contact the prescribing care team. For a manufacturer savings program, consult that program’s current terms and contact route.
These are navigation principles, not an assertion that every program divides responsibility identically. Read the actual agreement and order confirmation. If a seller refers you elsewhere, ask which organization has responsibility for the specific issue and request that information in writing.
Keep a simple record of the brand and presentation, care provider, platform, pharmacy and payment collector. That record is especially useful when a service advertises an all-in price or a manufacturer discount: it makes clear who is promising each component and who can verify it.
The useful takeaway
The short answer is Novo Nordisk for Ozempic and Wegovy, and Lilly for Zepbound. The more useful purchasing answer also identifies the clinician, platform and pharmacy involved in the actual service.
Knowing a brand’s company does not authenticate an individual shipment, verify a pharmacy license or decide whether treatment is appropriate. It does help avoid a common confusion: the provider that connects you with care is not necessarily the company that makes the branded medicine, and a compounded offering should not inherit that brand identity.